2 mL blood sample
Minimally invasive, substantially reducing discomfort and the burden of blood collection.
Circulating Tumor Cell (CTC) Automated Testing System and Services
Blood collection takes about three minutes. The test provides supplementary information for cancer-risk assessment and follow-up.
Good Future specializes in CTC testing, combining a 2 mL blood sample with negative-selection technology, cellular imaging, and structured reporting. Our proprietary negative-selection technology preserves a broader range of CTC phenotypes, helping provide more complete results and useful information for interpretation. The findings may also serve as a reference for ongoing health monitoring, risk assessment, and consultation with a physician.
5 business days
Fast report turnaround helps clinicians plan treatment earlier.
50+ partner institutions
Available through major hospitals and specialist clinics across Taiwan.
Taiwan’s first CTC laboratory to obtain ISO 17025 accreditation
Accredited laboratory workflows support consistent and reliable reporting.
Key Differentiators
What makes Good Future different
Understand the service features that distinguish Good Future’s CTC testing approach.
Differentiator 01
Negative selection workflow
Removes normal blood cells first and preserves more clinically meaningful CTC phenotypes.
Differentiator 02
Epithelial + mesenchymal testing
Supports review of both epithelial and mesenchymal phenotypes instead of relying on a single signal.
Differentiator 03
Image-supported reporting
Reports include image evidence and interpretation details alongside summary results.
Differentiator 04
Support for follow-up use
Designed to support longitudinal follow-up, molecular testing, and research applications.
Who Is This Test For
Who may benefit from CTC testing?
CTC testing may be considered based on risk profile, suspicious findings, or follow-up needs.
Individuals with higher cancer risk
Family history of cancer
Frequent smoking or drinking
People with concerning health findings
Abnormal imaging findings
Abnormal blood tumor markers
Cancer patients
Monitor treatment response
Monitor risk of recurrence
Partnerships and Milestones
Partnerships and Milestones
From technology licensing and system development to clinical, insurance, and overseas collaboration, Good Future continues to expand where CTC testing can be applied.
Technology licensed from Chang Gung University
Inventec Appliances
Taipei Veterans General Hospital
Global Life
Nanshan Life Insurance
CTC separation technology licensing and automated system development
Good Future's CTC separation technology is licensed from Chang Gung University. Its fully automated CTC testing system was developed in collaboration with Inventec Appliances to integrate sample processing and testing workflows.
Taipei Veterans General Hospital collaboration experience
Collaboration with Taipei Veterans General Hospital helped align the system and service workflow with medical-center practice and strengthen clinical understanding of sampling and image review.
Won the 17th National Innovation Award
The 17th National Innovation Award provided external recognition and strengthened trust in the R&D progress behind Good Future’s automated detection system.
Global Life and Nan Shan Life cooperation
Partnerships with Global Life and Nan Shan Life expanded access to CTC testing through corporate and insurance wellness programs.
Wellspring Partnership in Malaysia
Good Future is working with Malaysian smart-health company Wellspring on projects involving CTC testing, gut health, and probiotics.
Malaysia regulatory milestone
The CTC testing system received Malaysian medical device registration in August 2025, establishing a regulatory foundation for local market introduction.
More Entry Points
More Services and Resources
In addition to testing services, you can quickly reach blood collection, product, and wellness information from the sections below.
Blood Collection Sites
Search by city and district to find blood collection partners and site information.
Products
Browse testing systems, consumables, and related product information.
Health Products
Browse products designed for everyday wellness support.
Featured Resources
Featured news and resources
Quickly review brand updates, technical insights, and video content.
Good Future and Chung Shan Medical University Hospital publish breast cancer CTC study in MDPI Diseases
Quickly review Good Future’s latest published breast cancer CTC study and its core findings.
Circulating Tumor Cell Detection Principle
Learn how negative selection and image-based reporting support CTC testing.
Good Future Knowledge Series | CTC overview
A concise introduction to the core concepts of circulating tumor cells (CTCs), designed to help first-time viewers build a clear foundation.